Search
SOLACI Congress
HomeFileCoronary disease

Coronary disease

View Category

Chronic Ischemic cardiopathy

ESC 2020 | Post PCI Trimetazidine: No Adverse Events or Great Benefits

Trimetazidine in addition to optimal medical therapy in patients undergoing coronary PCI does not change events rate...
solaci -
Learn More
Coronary disease

4° ProEducar Educational Meeting – Complex Coronary Intervention

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be...
solaci -
Learn More
Acute coronary syndromes

Can Aspirin Use Be Interrupted After Angioplasty?

Aspirin discontinuation 1 to 3 months after angioplasty with continued P2Y12 inhibitor therapy reduces the bleeding risk without...
solaci -
Learn More
Coronary disease

SOLACI Webinar | Cardiac Arrhythmias

Watch again our Webinar on "Cardiac Arrhythmias” on our Youtube account.  We are interested in your opinion. Please,...
solaci -
Learn More
Bifurcations

Is the Paradigm for Bifurcation Lesions Changing Once More?

Four years ago, we published a summary of the SMART-STRATEGY Study saying that, with bifurcation lesions, “less...
solaci -
Learn More
Acute coronary syndromes

LATAM: Information on the Impact of the Pandemic with a Focus on MI

There are several studies from all corners of the world (China, Europe, USA) presenting data on the...
solaci -
Learn More
Clinical Cases

The Fellow’s Corner | 1st Clinical Case: All That Glitters Is Not Gold

We present the first clinical case in the section “The Fellow’s Corner”, aimed at fellows in Latin...
solaci -
Learn More
Coronary disease

SOLACI Webinar | Cardiac Arrhythmias

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be...
solaci -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Endoleaks after endovascular repair of complex aortic aneurysms: always reintervene or monitor with CTA?

Dr. Juan Manuel Pérez - 0
Endovascular repair of thoracoabdominal aneurysms requiring sealing above the renal arteries, with preservation of visceral vessels using fenestrated and/or branched devices (F/B-EVAR), has become...

Is it safe to use negative chronotropic drugs early after TAVI?

Dr. Juan Manuel Pérez - 0
TAVI is associated with a relevant incidence of conduction system disturbances and the development of atrioventricular block that may require permanent pacemaker implantation. Many...

Long-Term Cardiovascular Risk in Patients With ANOCA: A Clinical Reality to Consider?

Dr. Omar Tupayachi - 0
Chronic stable angina (CSA) remains one of the most frequent reasons for referral to diagnostic coronary angiography (CAG). In a substantial proportion of these...

Institutional News

SOLACI Wishes You Happy Holidays

solaci - 0
From the heart, Happy Holidays! The Latin American Society of Interventional Cardiology wishes all its members and the medical community across the continent a very Merry Christmas...

Condolences on the passing of Cristiam Arancibia

solaci - 0
The Latin American Society of Interventional Cardiology deeply mourns the passing of Lic. Cristiam Arancibia, first Director of the Chapter of Technicians and Nurses,...

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

solaci - 0
Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy